Most breast cancer survivors underestimate the risk of cancer returning: New Canadian study

Printer-friendly version

Despite their fight with breast cancer and the wealth of resources available, survivors remain uninformed of the risk of cancer recurrence, according to a new important Canadian survey. The survey, led by the Canadian Breast Cancer Network (CBCN) and conducted by Ipsos-Reid, shows that only one in 10 women surveyed are aware of their risk of relapse after five years of tamoxifen treatment.

For the full news release.